Oxford Global Conferences are pleased to announce the 2nd Annual Discovery Chemistry & Drug Design Congress, taking place at the Intercontinental Geneva on 2 & 3 June 2014. This two day congress has been developed to offer discovery chemistry leaders an executive platform for networking and discussion. The discovery chemistry industry is moving into a new era of collaboration. Recognising the importance of de-risking candidates as early as possible, many organisations are looking at ways of drawing in expertise from a range of research areas. This congress will explore novel solutions created by hybrid biology-chemistry approaches to drug design, cohesive DMPK strategies across the early pipeline and recent advances in genomic and informatics applications. Our expert speakers will discuss methods of improving solubility, drugability and potency, while combatting the challenges of an increased demand for molecular complexity. Delegates will hear case studies covering a range of topics, including fragment based discovery, computer aided design for biologics and the role of natural products in discovery chemistry. Poster presentations, Q&A sessions and dedicated networking breaks offer delegates the chance to meet with VPs, Directors and Senior Managers working in medicinal chemistry, drug design, flow chemistry, chemical genetics, discovery technology and computational chemistry.